{"DataElement":{"publicId":"5985732","version":"1","preferredName":"Breast Cancer AJCC Edition 8 Clinical Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for breast carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"BRST_AJC8_CLN_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188689","version":"1","preferredName":"Breast Tumor Clinical M Stage","preferredDefinition":"Information related to clinical M stage for a breast tumor.","longName":"BRST_TUMOR_C_M","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E53F0DC4-6E65-6553-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"TAYLORT","dateModified":"2017-11-17","changeDescription":"11/17/17 tt associated with CS/CSI. 9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified. CSI? \"","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6005691","version":"1","preferredName":"Breast Carcinoma American Joint Committee on Cancer Edition 8 M Category","preferredDefinition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6005691v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"cM1","valueDescription":"Breast Cancer cM1 TNM Finding v8","ValueMeaning":{"publicId":"6005693","version":"1","preferredName":"Breast Cancer cM1 TNM Finding v8","longName":"6005693","preferredDefinition":"Breast cancer with distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cM1 TNM Finding v8","conceptCode":"C139395","definition":"Breast cancer with distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEAAC13-F192-0D55-E053-F662850A062E","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71351E9C-81F5-04E0-E053-F662850AAEC9","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","deletedIndicator":"No"},{"value":"pM1","valueDescription":"Breast Cancer pM1 TNM Finding v8","ValueMeaning":{"publicId":"6005737","version":"1","preferredName":"Breast Cancer pM1 TNM Finding v8","longName":"6005737","preferredDefinition":"Breast cancer with distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pM1 TNM Finding v8","conceptCode":"C139410","definition":"Breast cancer with distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEB6CF7-A4DD-4588-E053-F662850A8131","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71351E9C-81CD-04E0-E053-F662850AAEC9","beginDate":"2018-07-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Breast Cancer cM0 TNM Finding v8","ValueMeaning":{"publicId":"6005697","version":"1","preferredName":"Breast Cancer cM0 TNM Finding v8","longName":"6005697","preferredDefinition":"Breast cancer without clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the cM0 category. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cM0 TNM Finding v8","conceptCode":"C139393","definition":"Breast cancer without clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the cM0 category. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEAAC13-F1DE-0D55-E053-F662850A062E","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71351E9C-81E1-04E0-E053-F662850AAEC9","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","deletedIndicator":"No"},{"value":"cM0(i+)","valueDescription":"Breast Cancer cM0(i+) TNM Finding v8","ValueMeaning":{"publicId":"6005695","version":"1","preferredName":"Breast Cancer cM0(i+) TNM Finding v8","longName":"6005695","preferredDefinition":"Breast cancer in which there is no clinical or radiographic evidence of distant metastases in the presence of tumor cells or deposits no larger than 0.2 mm detected microscopically or by molecular techniques in circulating blood, bone marrow, or other nonregional nodal tissue in a patient without symptoms or signs of metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cM0(i+) TNM Finding v8","conceptCode":"C139394","definition":"Breast cancer in which there is no clinical or radiographic evidence of distant metastases in the presence of tumor cells or deposits no larger than 0.2 mm detected microscopically or by molecular techniques in circulating blood, bone marrow, or other nonregional nodal tissue in a patient without symptoms or signs of metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BEAAC13-F1B8-0D55-E053-F662850A062E","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BEAAC13-F1D1-0D55-E053-F662850A062E","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6356799","version":"1","preferredName":"Breast Cancer TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C139390:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer TNM Finding v8","conceptCode":"C139390","definition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71351E9C-818A-04E0-E053-F662850AAEC9","latestVersionIndicator":"Yes","beginDate":"2018-07-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5BEA94F0-EE25-3BA5-E053-F662850AA77F","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt.  7/17/18 tt updated/Focus Group recommendations. 11/17/17 tt associated with CS/CSI. 10/19/17 tt created for standardization; supercedes VD 3419277.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2180933","version":"1","longName":"FNL Research Activities","context":"CIP","ClassificationSchemeItems":[{"publicId":"6788757","version":"1","longName":"QIN Breast Study","context":"CIP"}]},{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"7035094","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000338","version":"1","longName":"Breast","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001791","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"Clinical M","type":"QIN Breast Study","context":"CIP"},{"name":"CIP","type":"USED_BY","context":"CIP"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"clinical_TNM_class_M_8","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Clinical M category","type":"Preferred Question Text","description":"Clinical M category","url":null,"context":"NCI Standards"},{"name":"MCL-PCA-1","type":"Alternate Question Text","description":"Clinical TNM Class M","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"breast_v1-2_08sep2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5AB9CADB-802D-119D-E053-F662850ABA66","latestVersionIndicator":"Yes","beginDate":"2017-10-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-04","modifiedBy":"COLBERTM","dateModified":"2021-11-29","changeDescription":"11/29/21 mr Added alt name, alt def, ref doc, CSI for MCL PCA breast per DCT.   5-3-19 released; tmt.  7/17/18 tt updated/Focus Group recommendations.  11/17/17 tt associated with CS/CSI. 10/19/17 tt associated with new VD. 10/4/17 tt created for standardization. Incomplete pending updates to VD per NCIt Ed 8 caDSR concept loading; supercedes CDE 3419391.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}